´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ(ÀÌ»çÀå·¼ÛÁ¤ÇÑ)°¡ ¿À´Â 18ÀÏ(¼ö)~20ÀÏ(±Ý) ±×·£µå ¿öÄ¿Èú¼¿ï È£ÅÚ¿¡¼ LMCE (Laboratory Medicine Congress & Exhibition) 2017°ú Á¦58Â÷ Çмú´ëȸ¸¦ µ¿½Ã¿¡ °³ÃÖÇÑ´Ù.
Laboratory Medicine in the Era of Disruptive Technology’¸¦ ½½·Î°ÇÀ¸·Î °³ÃֵǴ LMCE 2017Àº Áö³ 2016³â¿¡ À̾î 2³â° °³ÃÖÇÏ´Â ±¹Á¦Çмú´ëȸÀÌ´Ù.
À̹ø Çмú´ëȸ´Â 4Â÷ »ê¾÷Çõ¸í ¹× IT ±â¼úÀÇ ¹ß´Þ°ú ÇÔ²² ‘¾÷°è¸¦ »õ·Ó°Ô ÀçÆí¼ºÇÏ°í ½ÃÀåÀ» Á¡À¯ÇÏ°Ô µÉ ½Å±â¼úÀ̳ª ¼ºñ½º’°¡ Áø´Ü°Ë»çÀÇÇÐ ºÐ¾ß¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÏ¿© ´Ù¾çÇÑ °üÁ¡¿¡¼ ´Ù·ê ¿¹Á¤ÀÌ´Ù.
Çмú´ëȸ´Â 1,000¸í ÀÌ»ó Âü¼®ÀÌ ¿¹»óµÇ´Â °¡¿îµ¥ ÇØ¿Ü¿¡¼ Åõ°íÇÑ ¿¬Á¦ 86°³¸¦ Æ÷ÇÔÇØ ÃÑ 25°³±¹ 362ÆíÀÇ ±¸¿¬ ¹× Æ÷½ºÅÍ ¿¬Á¦ ¹ßÇ¥°¡ ÁøÇàµÉ ¿¹Á¤ÀÌ´Ù.
ÀÌ´Â Áö³ 2016³â(13°³±¹ 308Æí)º¸´Ù ´õ ´Ù¾çÇÑ ±¹°¡¿¡¼ Âü¿©ÇÏ´Â °ÍÀ¸·Î, Âü°¡ÀÚµéÀÇ ÃֽŠ¿¬±¸ ¼º°ú¸¦ °øÀ¯ÇÏ´Â Åä·ÐÀÇ ÀåÀÌ µÉ °ÍÀ¸·Î ±â´ëµÈ´Ù.
À̸¦ ¹ÙÅÁÀ¸·Î À̹ø Çмú´ëȸ´Â 3°³ÀÇ ±âÁ¶¿¬¼³(plenary lecture), 4°³ÀÇ Çٽɿ¬¼³(keynote speech), 17°³ÀÇ ½ÉÆ÷Áö¾ö, 13°³ÀÇ ±³À°¿öÅ©¼óÀ¸·Î ±¸¼ºµÆ´Ù. ¸ðµç ±âÁ¶¿¬¼³, Çٽɿ¬¼³, ±³À°¿öÅ©¼ó, 13°³ÀÇ ½ÉÆ÷Áö¾öÀº ¿µ¾î·Î ÁøÇàµÈ´Ù.
±âÁ¶¿¬¼³·Î´Â ¹Ì±¹ÀÓ»óÈÇÐȸ(American association for clinical chemistry, AACC) ȸÀåÀÎ ¹Ì±¹ Pennsylvania ´ëÇÐÀÇ Michael J. Bennett ±³¼ö°¡ ‘Saving children’s lives by newborn screening for metabolic disorders’¶ó´Â ÁÖÁ¦·Î °¿¬À» ÇÒ ¿¹Á¤ÀÌ´Ù.
Ư°À¸·Î´Â WHO classification of tumors of the hematopoietic and lymphoid tissuesÀÇ °³¹ß¿¡ ÇÙ½ÉÀûÀÎ ¿ªÇÒÀ» ¼öÇàÇÑ ¹Ì±¹ National Cancer InstituteÀÇ Elaine S. Jaffe ¹Ú»ç°¡ ‘Diagnosis of lymphoid neoplasms: A multimodality approach’¶ó´Â ÁÖÁ¦·Î ÁøÇàÀ» ÇÑ´Ù.
¶Ç ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ ȸÀåÀ» ¸Ã°í ÀÖ´Â ¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø ±èÁ¾¿ø ±³¼ö°¡ ‘Towards an era of precision medicine’ °ÀǸ¦ ÅëÇØ ÃÖ±Ù ÁÖ¸ñ ¹Þ°í ÀÖ´Â Á¤¹ÐÀÇÇÐÀÇ ÃֽŠÁö°ß¿¡ ´ëÇØ ´Ù·ê ¿¹Á¤ÀÌ´Ù.
ƯÈ÷, ‘Æı«Àû Çõ½Å’À̶ó´Â À̹ø Çмú´ëȸ ½½·Î°ÇÀÇ Àǹ̸¦ Àß Ç¥ÇöÇÏ´Â Çٽɿ¬¼³µéµµ ¿¹Á¤µÇ¾îÀÖ¾î °ü½ÉÀÌ ¸ð¾ÆÁö°í ÀÖ´Ù.
ÃÖ±Ù °¢±¤ ¹Þ°í ÀÖ´Â ÀΰøÁö´É°ú °ü·ÃÇÏ¿© ¼¿ïÀÇ´ë Á¤º¸ÀÇÇб³½Ç ±èÁÖÇÑ ±³¼ö°¡ ‘Artificial intelligence for better health care’¶ó´Â ÁÖÁ¦·Î Ư°À» ÁøÇàÇÑ´Ù.
¶Ç Àεµ³×½Ã¾Æ ÀÓ»óº´¸®ÇÐȸ ȸÀåÀÎ Padjadjaran ´ëÇÐ Ida Parwati ±³¼ö°¡ ‘Adding value the role of clinical pathologist and laboratory medicine in reducing antimicrobial resistance’¶ó´Â ÁÖÁ¦ÀÇ Æ¯°À» ÁøÇàÇÒ ¿¹Á¤ÀÌ´Ù.
ÀϺ» Chiba ´ëÇÐ Fumio Noruma ±³¼ö´Â ‘Applications of proteomics and mass spectrometry to laboratory medicine’À» ÁÖÁ¦·Î Áø´Ü°Ë»çÀÇÇÐ ºÐ¾ß¿Í °ü·ÃµÈ ´Ù¾çÇÑ ÃÖ½ÅÁö°ßÀ» ¼Ò°³ÇÒ ¿¹Á¤ÀÌ´Ù.
ÀÌ¿ÍÇÔ²² À̹ø Çмú´ëȸ´Â ´Ù¾çÇÑ ±¹³»¿Ü ´Üüµé°ú ´Ù¾çÇÑ ¼¼¼ÇÀ» ÁغñÇØ ±¹Á¦Çмú´ëȸ À§»ó °È¿¡ ³ª¼¹´Ù.
¿ì¼± ¹Ì±¹ÀÓ»óÈÇÐȸ(AACC) ¹× ±¹Á¦Áø´ÜÇ÷¾×ÇÐȸ(International Society for Laboratory Hematology, ISLH)¿Í °¢°¢ ‘Determining what works: Clinical effectiveness and value based laboratory testing’, ‘New trends of diagnostic hematology’¶ó´Â ÁÖÁ¦·Î °øµ¿ ½ÉÆ÷Áö¾öÀ» ÁøÇàÇÑ´Ù.
¶Ç ¹Ì±¹ÀÓ»ó°Ë»çÇ¥ÁØ¿¬±¸¿ø(Clinical and Laboratory Standards Institute, CLSI) ¹× ¹Ì±¹º´¸®ÇÐȸ(College of American Pathologists, CAP)¿Í ÇÔ²² ÁøÇàÇϴ ǥÁØÁöħ ¹× ÀÎÁõ °ü·ÃµÈ ½ÉÆ÷Áö¾öµµ ¿¹Á¤µÇ¾î ÀÖ´Ù.
Áø´Ü°Ë»çÀÇÇÐÀç´Ü(¿ì¼ö°Ë»ç½Ç ½ÅÀÓÀÎÁõ), Áúº´°ü¸®º»ºÎ(±¹°¡°¨¿°º´ À§±â ´ëÀÀ)¿Í ÇÔ²² ÁøÇàÇÏ´Â ¼¼¼Çµµ ¸¶·ÃµÇ¾î ÀÖ¾î °ü½ÉÀÌ ³ôÀº »óȲÀÌ´Ù.
ÀÌ¿Ü¿¡µµ ÀϺ», ű¹, Àεµ³×½Ã¾Æ, Àεµ µî ´Ù¾çÇÑ ¾Æ½Ã¾Æ Áö¿ª ±¹°¡¿¡¼ÀÇ Áø´Ü°Ë»çÀÇÇÐ ºÐ¾ß Àü¹®ÀÇ ¼ö·Ã °úÁ¤¿¡ ´ëÇØ ¼Ò°³ÇÏ°í °øÀ¯ÇÏ´Â ¼¼¼Çµµ ¿¹Á¤µÇ¾î ÀÖ¾î ¹ú½áºÎÅÍ Âü¼® ȸ¿øµéÀÌ ³ôÀº °ü½ÉÀ» º¸ÀÌ°í ÀÖ´Ù.
È«¹ÌÇö ±âÀÚ mi9785@naver.com
<ÀúÀÛ±ÇÀÚ © ÀÇ»ç½Å¹®, ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>